{
}
The Global Metagenomic Sequencing Market is projected to grow from US$ 1.41 billion in 2023 to US$ 4.39 billion by 2030, with a CAGR of 17.6%. Key factors driving this growth include increased demand, technological advancements, and a broadening customer base, alongside insights into competitive dynamics and market segmentation. Major players include Illumina, QIAGEN, and Thermo Fisher Scientific, with applications spanning drug discovery, disease diagnosis, and environmental remediation.
The healthcare analytical testing services market is projected to grow from $5.72 billion in 2023 to $11.29 billion by 2028, driven by rising chronic disease cases and technological advancements. North America led the market in 2023, with significant contributions from telemedicine and innovative drug testing platforms. Key players include Charles River Laboratories and Thermo Fisher Scientific.
The global Healthcare Testing, Inspection, and Certification Outsourcing market is projected to grow from $4.9 billion in 2024 to $9 billion by 2032, driven by increasing regulatory demands and a focus on patient safety. Key trends include the adoption of digital solutions and AI, alongside rising outsourcing in emerging markets. However, challenges such as data security concerns and complex regulatory landscapes persist, impacting smaller facilities' ability to comply with certification standards.
Eurofins Scientific faces significant stock market penalties due to disappointing growth, particularly in biopharmaceutical services, leading to a lowered revenue forecast for 2024. The company reported third-quarter revenues of 1.72 billion euros, falling short of expectations, with organic growth at just 4.4%. An independent audit confirmed the integrity of its cash accounting practices, countering allegations of financial misconduct.
Eurofins Scientific SE
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
global metagenomic sequencing market poised for significant growth by 2030
United States Dollar
BGI Group
GENEWIZ
Novogene Corporation
Eurofins Scientific SE
PerkinElmer
Macrogen
Zymo Research
Nugen Technologies Inc.
Takara Bio Inc.
Swift Biosciences
Thermo Fisher Scientific Inc.
BaseClear
MR DNA (Molecular Research)
Diversigen
CosmosID
Oxford Nanopore Technologies
NEW England Biolabs Inc.
Illumina, Inc.
Qiagen N.V.
Microsynth AG
Priya Pandey
Viju Shah
Show more
11:59 26.11.2024
healthcare analytical testing services market projected to reach 11.29 billion by 2028
United States Dollar
Eurofins Scientific SE
Merck KGaA
Intertek Group plc
Charles River Laboratories International, Inc.
Thermo Fisher Scientific Inc.
WuXi AppTec
Merck KGaA
Charles River Laboratories International Inc.
Thermo Fisher Scientific Inc.
Danaher Corporation
Show more
06:51 13.11.2024
healthcare testing inspection and certification outsourcing market projected to grow significantly by 2032
Applus+ Technologies Inc
Element Materials Technology
Intertek Group plc
CSA Group Testing & Certification Inc.
UL Solutions Inc.
ALS Ltd.
SGS SA
TÜV SÜD AG
DEKRA CERTIFICATION B.V.
Eurofins Scientific SE
CHN
JPN
PHL
KOR
MYS
TWN
THA
IND
HKG
IDN
SGP
VNM
AUS
Harry
Joe Biden
Show more
15:13 06.11.2024
eurofins scientific faces stock market decline amid disappointing growth and audits
10:43 22.10.2024
Trending
Subcategory
Countries:
Companies:
Currencies:
People: